Bile acid, fibroblast growth factor-19, and glucagon-like peptide-1 levels in the long term after bariatric surgery in patients with type 2 diabetes

被引：0
|
作者：
Kim, M. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
544
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [1] Long-term levels of bile acids, fibroblast growth factor-19, and glucagon-like peptide-1 after bariatric surgery
    Kim, Mee Kyoung
    Kwon, Hyuk-Sang
    Baek, Ki-Hyun
    Song, Ki-Ho
    ASIAN JOURNAL OF SURGERY, 2025, 48 (01) : 356 - 362
  • [2] Intact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes
    Lee, Soushou
    Yabe, Daisuke
    Nohtomi, Kyoko
    Takada, Michiya
    Morita, Ryou
    Seino, Yutaka
    Hirano, Tsutomu
    ENDOCRINE JOURNAL, 2010, 57 (02) : 119 - 126
  • [3] Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Courtney, Hamish
    Nayar, Rahul
    Rajeswaran, Chinnadorai
    Jandhyala, Ravi
    DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 79 - 87
  • [4] Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes
    Mannucci, E
    Tesi, F
    Bardini, G
    Ognibene, A
    Petracca, MG
    Ciani, S
    Pezzatini, A
    Brogi, A
    Dicembrini, I
    Cremasco, F
    Messeri, G
    Rotella, CM
    DIABETES NUTRITION & METABOLISM, 2004, 17 (06) : 336 - 342
  • [5] Glucagon-like peptide-1 therapy for youth with type 2 diabetes
    Cho, Young Min
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 362 - 363
  • [6] Effectiveness of glucagon-like peptide-1 agonists in type 2 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (03): : 359 - 360
  • [7] Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
    Toft-Nielsen, MB
    Madsbad, S
    Holst, JJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08): : 3853 - 3860
  • [8] Therapeutics Glucagon-like peptide-1 analogues for type 2 diabetes
    Wilding, John P. H.
    Hardy, Kevin
    BRITISH MEDICAL JOURNAL, 2011, 342 : 433 - 435
  • [9] Glucagon-like peptide-1 in type 2 diabetes:: the β-cell and beyond
    Nauck, Michael A.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 2 - 13
  • [10] Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
    Edwards, C. M. B.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (04) : 198 - 201
12345